Lider du av tvångssyndrom? Just nu bedriver vi en studie där vi jämför olika varianter av KBT-behandling vid tvångssyndrom. Rekryteringen är öppen hela 2017 och det är gratis att delta i studien.
Den som deltar i studien blir lottad till en av tre KBT-behandlingar, som alla pågår i 14 veckor:
- Behandling på OCD-programmet (Huddinge Sjukhus)
- Internet-behandling med behandlarstöd
- Internet-behandling på egen hand
Före och efter behandlingen får deltagarna komma till Huddinge Sjukhus för utvärdering. Vi gör också uppföljningar 3 och 12 månader efter behandlingen.
Du anmäler intresse till studien via följande länk: http://web.internetpsykiatri.se/behandling/tvangssyndrom/
Vi tar även emot remisser till studien. Se den här länken för mer information: https://rucklab.com/for-patients/
För mer information, kontakta någon av forskarna bakom studien:
Projektledare Lina Lundström (email@example.com) & Oskar Flygare (firstname.lastname@example.org)
Ansvarig forskare Christian Rück (email@example.com)
This week, our latest study on hoarding symptoms in young people was published in Plos One. In this study, we used data from the Swedish Twin Registry on twins in 3 samples (ages 15, 18 and 20-28 years). We had access to data for more than 16 000 twins (largest sample to date) and estimated the heritability at every age and also conducted longitudinal analyses on twins with data at ages 15 and 18. Our results showed that hoarding symptoms were heritable at all ages although the heritability decreased somewhat with age. Symptoms of hoarding were also moderately stable between ages 15 and 18, and this stability was largely due to genetic factors while non-shared environmental factors had a time-specific effect.
Follow the link below to access the publication:
Dagens Nyheter har en artikelserie om BDD där flera av våra medarbetare är med.
Läs här (IntrenetKBT med Jesper Enander) eller här (BDD och män med Christian Rück).
Jesper Enander today received his PhD after successfully defending his thesis today. Congratulations Jesper!
Jesper (the tallest) surrounded by his supervisors. To the left the opponent Prof Ulrike Buhlmann being distracted by Prof Jerker Hetta from the examination board.
The examination board: Klaas Wijma, Linköping University, Jerker Hetta and Kalle Lundgren, KI.
Our collaborator Manuel Mattheisen, Associate Professor at Århus University, is now officially affiliated to Karolinska Institutet and our group. He studied medicine at the University in Bonn and went on to be a research follow at Harvard Medical School before moving to Denmark. We are fortunate to enjoy his deep expertise in genetical methods. Check out his quite spectacular publication list here.
Jesper Enander just nailed his thesis to a plank at the Karolinska library. This means that the thesis is now open to the public and will be publicly defended May 5th.
Our treatment study of Body Dysmorphic Disorder published in the BMJ was yesterday awarded the best publication of the year by the Department of Clinical Neuroscience at Karolinska Institutet!
Jesper Enander graciously holding the award.
Jesper is about to defend his thesis titled: “Etiology, prevalence, and development of a novel treatement for body dysmorphic disorder” May 5 at 09.00 in Lecture hall H1, Alfred Nobels Allé 23, Campus Flemingsberg. Do not miss!
His Opponent will be Professor Ulrike Buhlman, University of Münster.
Associate Professor Kalle Lundgren, Karolinska Institutet, Department of Molecular Medicine and Surgery
Professor Klaas Wijma, Linköping University, Department of Clinical and Experimental Medicine
Professor Jerker Hetta, Karolinska Institutet, Department of Clinical Neuroscience
Associate Professor Christian Rück, Karolinska Institutet, Department of Clinical Neuroscience
Professor David Mataix-Cols, Karolinska Institutet, Department of Clinical Neuroscience
Professor Paul Lichtenstein, Karolinska Institutet, Department of Medical Epidemiology and Biostatistics
Associate Professor Brjánn Ljótsson, Karolinska Institutet, Department of Clinical Neuroscience
It has been an intense week for those involved in the treatment of OCD in children and adolescents. Fabian Lenhard has successfully defended his thesis, congratulations Fabian! His opponent was Professor John Piacentini from University of California, Los Angeles. Professor Piacentini is an experienced clinician and researcher in pediatric OCD. Yesterday he gave a lecture on the research frontiers in this field.
Fabian and his supervisors. From left to right: Erik Andersson, Eva Serlachius, Fabian Lenhard, Christian Rück, and David Mataix-Cols
Internet-delivered CBT for adolescents with OCD
The topic of Dr. Lenhard’s thesis is Internet-delivered Cognitive Behavior Therapy for Adolescents with Obsessive-Compulsive Disorder. You can find the thesis here: https://openarchive.ki.se/xmlui/handle/10616/45535
He has developed and tested the treatment in an open trial and a randomized controlled trial. Analyses on cost-effectiveness and predictors of outcome are underway.
Fabian during his dissertation
The results from both the open trial and the randomized trial indicate that internet-delivered CBT is an effective treatment for adolescents with OCD. The pre-post within-group effect sizes were large in both trials.
Link to the open trial: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0100773
Link to the randomized trial: http://www.jaacap.com/article/S0890-8567(16)31857-3/abstract
Main results from the open trial.
Main results from the randomized trial
Professor John Piacentini: Optimizing Outcomes for Pediatric OCD
During his visit to Sweden, Professor Piacentini talked about research that aims to optimize outcomes in pediatric OCD. After receiving CBT, around 40 % of patients are in remission. While our treatments are effective for some, we still have a long way to go in order to treat every child and adolescent with OCD. Looking into specific mechanisms of change might be a way to optimize the current treatments.
Professor Piacentini of UCLA
Some suggested mechanisms include expectations of recovery (which might be mediated by home work compliance), the ability of a therapist to push exposures, and affect labeling (”I feel scared”) rather than cognitive restructuring during exposure.
Professor Piacentini also discussed recent work on neurotransmitters that directly target the underlying brain correlates of OCD. For example, glutamate levels might serve as a possible moderator of treatment outcome. We are awaiting the results from trials that aim to change glutamate levels pre-treatment to enhance the outcomes of CBT.
Don’t miss our dearest Fabian Lenhard’s thesis
to be publicly defended Friday March 23. Details on where here: http://ki.se/cns/kalender/disputation-fabian-lenhard
Your can download his thesis here: https://openarchive.ki.se/xmlui/handle/10616/45535